Loading clinical trials...
Loading clinical trials...
Observational Prospective Study, Evaluating the Standard of Care as Recommend by International Consensus With Zidovudine-Pegylated Interferon +/-Polychemotherapy in High Risk Adult-T-cell Lymphoma/Leukaemia (T-cell Lymphoma/Leukaemia) Followed by Allogeneic Transplant Among Eligible Patients Younger Than 65 Years Old
Conditions
Locations
2
Guadeloupe
CHU Pinteà Pitre/Abymes
Pointe-à-Pitre, Guadeloupe
CHU de Martinique
Fort-de-France, Martinique
Start Date
October 31, 2013
Primary Completion Date
February 1, 2018
Completion Date
March 1, 2021
Last Updated
June 3, 2021
NCT07388563
NCT06561048
NCT05679895
NCT04752826
NCT07203742
NCT07148180
Lead Sponsor
University Hospital Center of Martinique
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions